1. PHARMACOECONOMICS Presented by: Tavleen Kaur M.Pharmacology 1339246 2. "Not everything that can be counted counts, and not everything that counts can be counted."…
1. Rituximab or other MABs: why, where, when and how outside of MS. How to use these drugs, and when. Gavin Giovannoni Barts and The London School of Medicine and Dentistry…
Slide 1 Adverse Drug Reactions Jerrold H. Levy, MD Professor of Anesthesiology Emory University School of Medicine Director of Cardiothoracic Anesthesiology Emory Healthcare…
Slide 1 Pharmacoeconomics and Outcomes Research: Some Comments Dean Smith Michigan Student Chapter Slide 2 The International Society for Pharmacoeconomics and Outcomes Research…
Trends in Health Care Trends in Health Care HTR objective 02.04 Cost Containment Why does health care cost so much? And what can be done to bring the costs associated with…
Introduction to Pharmacotherapy Introduction to Pharmacotherapy Ghada A Bawazeer. MSc, PharmD. BCPS King Saud University-College of Pharmacy Sept. 2013 How many Prescription…
Workforce Development for Pharmaceutical Management: Pre-Service Component Gail Naimoli, Director, Capacity Building and Performance Improvement Critical Issues Series: Strengthening…
1.Nepal Health Research Council (NHRC) Ramshah Path, Kathmandu, Nepal National Ethical Guidelines For Health Research in Nepal And Standard Operating Procedures January 2011…